IL-22 is involved in the development of tumor diseases, the excess presence of IL-22 in the tumor microenvironment promotes tumor growth, inhibits apoptosis, and facilitates metastasis via STAT3 pathway activation [145]. The gene discussed is STAT3; the disease is neoplasm.